Alector enters into a licensing agreement with innovent biologics to develop and commercialize al008 in oncology indications in china

Al008 is alector’s dual function sirp-alpha inhibitor and fc gamma receptor activator antibody targeting the innate immune system for oncology...

ALEC Ratings Summary

ALEC Quant Ranking